scispace - formally typeset
R

Rolf Dario Frank

Researcher at Scripps Research Institute

Publications -  6
Citations -  457

Rolf Dario Frank is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Inflammation & Fondaparinux. The author has an hindex of 5, co-authored 6 publications receiving 431 citations. Previous affiliations of Rolf Dario Frank include Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia

TL;DR: Data demonstrate that hematopoietic cells are the major pathologic site of TF expression during endotoxemia and suggest that multiple protease-activated receptors mediate crosstalk between coagulation and inflammation.
Journal ArticleDOI

Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model

TL;DR: Egr-1 does contribute to the sustained expression of inflammatory mediators and to the maximal expression of TF at 8 hours in the kidneys and lungs, and these data indicate that Egr- 1 does not contribute toThe early inflammatory response in the kidney and lungs or the early systemicinflammatory response in endotoxemic mice.
Journal ArticleDOI

The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury

TL;DR: The data suggest that fondaparinux reduces kidney I/R injury primarily by inhibiting the recruitment of neutrophils, a synthetic pentasaccharide that selectively inhibits factor Xa in the coagulation cascade.
Journal ArticleDOI

A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury

TL;DR: The findings indicate that the anti-inflammatory activity of fondaparinux can be dissociated from its anticoagulant activity and that NAC-pentasaccharide is protective in kidney I/R injury.
Journal Article

Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers.

TL;DR: Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers -